CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences:

• Stephens Investment Conference in Nashville, TN. Fireside chat on Wednesday, November 19, 2025, at 8am CT.
• Piper Sandler Healthcare Conference in New York, NY. Presentation on Wednesday, December 3, 2025, at 4:30pm ET.

Live and archived webcasts of the presentations will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit www.caredx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251110292221/en/

Investor Relations Caroline Corner investor@caredx.com

Source: CareDx, Inc.